Tag: phase 2 trial

September 3, 2019

Aridis Tumbles After Phase 2 Trial Fails to Meet Endpoint

Aridis Pharmaceuticals dipped more than 6 percent on the news that AR-105 did not meet its primary endpoint in a...
September 3, 2019

Concert Pharmaceuticals Reports Positive CTP-543 Results

Concert Pharmaceuticals (NASDAQ:CNCE) has announced topline results from its Phase 2 trial evaluating CTP-543 in patients with moderate-to-severe alopecia areata....
August 27, 2019

Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products

Adaptimmune Therapeutics (NASDAQ:ADAP) has announced that it and Noile-Immune Biotech will co-develop SPEAR T-cell products based on the co-expression of...
August 26, 2019

Bio-Path Doses Patient in Amended Phase 2 Prexigebersen Trial

Bio-Path Holdings (NASDAQ:BPTH) has announced patient dosing in its amended Phase 2 trial of prexigebersen to treat acute myeloid leukemia...
March 6, 2019

Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia

Bio-Path Holdings (NASDAQ:BPTH) has announced a clinical update on its interim analysis from the Phase 2 trial of prexigebersen (BP1001)...
November 27, 2018

G1 Therapeutics Releases Phase 2 Data

Trilaciclib was tested in combination with chemotherapy and the checkpoint inhibitor Tecentriq in first-line small cell lung cancer patients.
November 27, 2018

G1 Therapeutics Announces Positive Myelopreservation Data

G1 Therapeutics (Nasdaq:GTHX), a clinical-stage oncology company, today announced positive topline data from its randomized, double-blind, placebo-controlled Phase 2 trial evaluating...